|
Jul 2
|
CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Revenue Q3 F2025 Resulting in Positve Adjusted EBITDA of $440,665.00 with Gross sales of $5.5 Million as well as 6% increase in Gross Earnings over the prior periods
|
|
Apr 14
|
CANADABIS ANNOUNCES CLOSING OF FINANCING
|
|
Mar 12
|
SIMPLY SOLVENTLESS ANNOUNCES HIGHLY ACCRETIVE ALL SHARE DEAL TO ACQUIRE CANADABIS (STIGMA GROW), CREATING #2 CONCENTRATES AND #5 PREROLL PRODUCER, AND CANADABIS ANNOUNCES $2.5 MILLION CONVERTIBLE DEBENTURE FINANCING
|
|
Dec 31
|
CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Record Revenue Q1 F2025 Resulting in $9.6M Gross with $321,569 in NET Earnings and an Adjusted EBITDA of $675,892
|
|
Jun 23
|
CanadaBis Capital Inc.'s (CVE:CANB) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
|
|
May 7
|
Canadabis Capital Expands into European Market with EU-GMP Partners
|
|
Jan 2
|
CANADABIS CAPITAL, WITH SUB STIGMA GROW, ANNOUNCES FISCAL Q1 2024 RESULTS HIGHLIGHTED BY YEAR-OVER-YEAR GROWTH IN REVENUE, ADJUSTED EBITDA¹ AND NET INCOME
|